Bora Pharmaceuticals Co., Ltd.
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 6472.TW | 603858.SS | 1795.TW | 003850.KS | AARTIDRUGS.NS | 4553.T | |
|---|---|---|---|---|---|---|
| Market cap | 49.62B | 15.95B | 44.76B | 695.42B | 40.63B | 179.68B |
| P/E (TTM) | 27.4 | 54.0 | 11.8 | — | 21.3 | 21.7 |
| Forward P/E | 12.2 | — | 7.1 | — | 16.0 | 12.4 |
| Price/book | 3.3 | 1.6 | 1.9 | — | 2.4 | 1.0 |
| Dividend yield | 2.70% | 3.67% | 1.61% | 1.91% | 0.44% | 2.28% |
| 1-year change | −40.54% | −9.81% | −42.88% | −6.59% | −6.77% | +25.13% |
| Today | +4.85% | +0.40% | +5.66% | +1.79% | −2.34% | +3.84% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.
Latest news
All 6472.TW news ›Taiwan's Bora Pharmaceuticals Posts Record September Revenue of NT$2.33 Billion, Up 35% Year-over-Year
Bora Pharmaceuticals reported September consolidated revenue of NT$2.33 billion (approximately $72.9 million), up 6.44% month-over-month and 35.13% year-over-year, setting a new single-month record for the second time since June.…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- finance.biggo.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.